53 related articles for article (PubMed ID: 21497162)
1. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
3. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
[TBL] [Abstract][Full Text] [Related]
4. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
5. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
[TBL] [Abstract][Full Text] [Related]
7. Natural autoantibody against apolipoprotein A-I. Detection and characterization of the monoclonal antibody established from normal unimmunized BALB/c mice.
Imai H; Suzuki S; Uchida K; Kikuchi K; Sugiyama H; Kohno H; Umeda M; Inoue K
J Immunol; 1994 Sep; 153(5):2290-301. PubMed ID: 8051425
[TBL] [Abstract][Full Text] [Related]
8. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
[TBL] [Abstract][Full Text] [Related]
9. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
[TBL] [Abstract][Full Text] [Related]
11. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
Goldstein SM; Leong J; Schwartz LB; Cooke D
J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
[TBL] [Abstract][Full Text] [Related]
12. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
13. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
[TBL] [Abstract][Full Text] [Related]
14. The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase.
Buckley MG; McEuen AR; Walls AF
J Pathol; 1999 Sep; 189(1):138-43. PubMed ID: 10451500
[TBL] [Abstract][Full Text] [Related]
15. Acrolein modifies apolipoprotein A-I in the human artery wall.
Shao B; O'brien KD; McDonald TO; Fu X; Oram JF; Uchida K; Heinecke JW
Ann N Y Acad Sci; 2005 Jun; 1043():396-403. PubMed ID: 16037261
[TBL] [Abstract][Full Text] [Related]
16. [Prokaryotic expression of human mast cell chymase gene and preparation of its polyclonal antibody].
Chen ZQ; Huang Z; He TW; Lu TT; Liang XD; He SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1025-7. PubMed ID: 17988583
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent binding of the plasma protein apolipoprotein A-I to two members of the annexin family.
Brownawell AM; Creutz CE
Biochemistry; 1996 May; 35(21):6839-45. PubMed ID: 8639635
[TBL] [Abstract][Full Text] [Related]
18. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
Fang Y; Gursky O; Atkinson D
Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
[TBL] [Abstract][Full Text] [Related]
19. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of N- and C-terminally truncated human apolipoprotein A-I.
Fang Y; Gursky O; Atkinson D
Biochemistry; 2003 Jun; 42(22):6881-90. PubMed ID: 12779343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
